...
首页> 外文期刊>Journal of vascular and interventional radiology: JVIR >Endovascular treatment of juxta-anastomotic venous stenoses of forearm radiocephalic fistulas: Long-term results and prognostic factors
【24h】

Endovascular treatment of juxta-anastomotic venous stenoses of forearm radiocephalic fistulas: Long-term results and prognostic factors

机译:血管内治疗前臂放射性头瘘的近吻合口吻合口静脉狭窄的长期结果和预后因素

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Purpose: To evaluate long-term results of endovascular procedures in treatment of venous juxta-anastomotic stenoses (JASs) of native forearm radiocephalic arteriovenous fistulas (AVFs) and to identify prognostic factors influencing these results. Materials and Methods: During a 124-month period, 147 endovascular interventions were performed in 75 forearm radiocephalic AVFs with JASs defined as stenoses located within the first 5 cm of the outflow vein. Prognostic factors included patient characteristics (age, sex, diabetes), AVF-related characteristics (location on forearm, age, maturity), stenosis-related characteristics (position relative to anastomosis, length, and degree), and degree of residual stenosis and delay of restenosis after the first endovascular procedure. Results: At 1 and 3 years, access primary patency (PP) rates were 46.6% (95% confidence interval [CI], 36.3%-59.9%) and 25.5% (95% CI, 15.7%-41.6%) and assisted PP (APP) rates were 81.3% (95% CI, 72.6%-91.1%) and 63.2% (95% CI, 50.6%-79.0%), respectively. Stenosis degree of 50%-75% (P =.017), stenosis length of 10 mm or more (P =.017), and time before first restenosis of less than 6 months (P =.03) significantly increased the frequency of endovascular procedures during follow-up. However, only the degree of residual stenosis after the first endovascular treatment significantly affected long-term APP (P =.039). When residual stenosis was less than 50%, 1- and 2-year access APP rates were 84.6% (95% CI, 75.8%-94.4%) and 76.1% (95% CI, 64.6%-89.6%), respectively. When it was at least 50%, the respective APP rates were 62.3% (95% CI, 38.9%-99.9%) and 46.8% (95% CI, 22.4%-97.7%). Conclusions: Endovascular treatment of JASs in forearm radiocephalic AVFs provides good long-term results except when the residual stenosis after the first procedure is 50% or more. In that case, the optimal treatment remains to be determined.
机译:目的:评估血管内手术治疗天然前臂放射头动静脉瘘(AVF)的静脉近吻合口狭窄(JAS)的长期结果,并确定影响这些结果的预后因素。材料和方法:在124个月的时间内,对75例前臂放射性头颅AVF进行了147次血管内干预,其JAS定义为位于流出静脉前5 cm内的狭窄。预后因素包括患者特征(年龄,性别,糖尿病),AVF相关特征(前臂位置,年龄,成熟度),狭窄相关特征(相对于吻合的位置,长度和程度)以及残余狭窄和延迟程度首次血管内手术后的再狭窄。结果:在1年和3年时,辅助性PP分别为46.6%(95%置信区间[CI],36.3%-59.9%)和25.5%(95%CI,15.7%-41.6%)。 (APP)发生率分别为81.3%(95%CI,72.6%-91.1%)和63.2%(95%CI,50.6%-79.0%)。狭窄程度为50%-75%(P = .017),狭窄长度为10 mm或更长(P = .017),首次再狭窄前的时间少于6个月(P = .03)显着增加了随访期间进行血管内手术。但是,仅首次血管内治疗后残余狭窄的程度会显着影响长期APP(P = .039)。当残余狭窄小于50%时,1年和2年的访问APP率分别为84.6%(95%CI,75.8%-94.4%)和76.1%(95%CI,64.6%-89.6%)。当其至少为50%时,各自的APP率分别为62.3%(95%CI,38.9%-99.9%)和46.8%(95%CI,22.4%-97.7%)。结论:前臂放射头性AVF的JAS的腔内治疗可提供良好的长期效果,除非第一次手术后残余狭窄为50%或更高。在那种情况下,最佳治疗方法仍有待确定。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号